Disposition pursuant to a tender of shares in a change of control transaction by Gordon Carl L of Theseus Pharmaceuticals

THRXDelisted Stock  USD 3.71  0.14  3.92%   
Slightly above 55% of Theseus Pharmaceuticals' investors are presently thinking to get in. The analysis of current outlook of investing in Theseus Pharmaceuticals suggests that some traders are interested regarding Theseus Pharmaceuticals' prospects. Theseus Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Theseus Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Theseus Pharmaceuticals I director. Disposition pursuant to a tender of shares in a change of control transaction

Read at finance.yahoo.com
Yahoo News
  
Theseus insider trading alert for disposition of common stock by Gordon Carl L, the corporate stakeholder, on 14th of February 2024. This event was filed by Theseus Pharmaceuticals I with SEC on 2024-02-14. Statement of changes in beneficial ownership - SEC Form 4

Theseus Pharmaceuticals Fundamental Analysis

We analyze Theseus Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theseus Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theseus Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Asset

Current Asset Comparative Analysis

Theseus Pharmaceuticals is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.

Theseus Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Theseus Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Theseus Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Theseus Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Theseus Pharmaceuticals Related Equities

ERASErasca   12.94   
0%
100.0%
DSGNDesign Therapeutics   4.67   
0%
36.0%
PMVPPmv Pharmaceuticals   4.32   
0%
33.0%
RCUSArcus Biosciences   3.24   
0%
25.0%
HOOKHookipa Pharma   2.38   
0%
18.0%
BPMCBlueprint Medicines   1.29   
0%
9.0%
MRSNMersana Therapeutics   0.88   
0%
6.0%
IMRXImmuneering Corp   0.48   
0%
3.0%
ELVNEnliven Therapeutics   0.21   
0%
1.0%
RLAYRelay Therapeutics   0.64   
4.0%
0%
DAWNDay One   0.65   
5.0%
0%
GLUEMonte Rosa   1.35   
10.0%
0%
TERNTerns Pharmaceuticals   1.44   
11.0%
0%
CGEMCullinan Oncology   2.08   
16.0%
0%
IPSCCentury Therapeutics   2.33   
18.0%
0%
XFORX4 Pharmaceuticals   5.13   
39.0%
0%
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Consideration for investing in Theseus Stock

If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Transaction History
View history of all your transactions and understand their impact on performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk